Apple details ResearchKit 2.0, with new features to help collect information about speech, hearing, and vision, a new PDF viewer, a refreshed UI, and more
After announcing ResearchKit 2.0 last week, Apple has shared more specifics on what the latest version will offer in iOS 12.
Context & Ripple Effects
ResearchKit has been quietly maturing since Apple introduced it in March 2015 as an open framework for medical research data collection, when the first wave of study apps showed how quickly iPhone-based trials could enroll participants. Coverage at the time focused on how the framework minimizes obstacles to participation — consent, onboarding, and passive data capture — which is exactly the layer this 2.0 refresh upgrades.
The timing matters: ResearchKit 2.0 ships inside iOS 12 alongside ARKit 2, signaling Apple is investing across its sensor-facing frameworks in one release cycle. And the new speech, hearing, and vision collection features read as groundwork for Apple's own research ambitions — the company later announced studies around hearing, heart, and women's health with a dedicated Research app for enrollment.
First-order effects
- Medical researchers running ResearchKit apps gain standardized tools for collecting speech, hearing, and vision data directly from participants' iPhones, replacing bespoke or clinic-only measurement with in-app capture.
- Developers of existing study apps get a refreshed UI and a built-in PDF viewer, reducing the custom interface work each research team previously had to maintain.
Second-order effects
- Lowering the cost of building a credible study app widens the funnel beyond the marquee institutions that launched the first ResearchKit apps in 2015, pushing smaller academic teams toward iPhone-based enrollment over traditional recruitment.
- By standardizing how sensory data is captured, Apple positions itself as the de facto pipeline between participants and researchers — including for its own hearing, heart, and women's health studies — rather than just a toolkit vendor.
Third-order effects
- If the pattern holds, the iPhone consolidates into a standardized clinical-grade measurement instrument, with Apple controlling both the SDK that third-party researchers build on and the first-party studies that compete for the same participants.
- Health-data collection at this scale keeps pressure on the consent-and-permission model ResearchKit was built around, making participant trust infrastructure a structural differentiator for whoever runs the largest research platform.
The trend: Smartphones are evolving from passive data sources into standardized instruments for clinical research, with Apple supplying both the framework and increasingly its own studies.